{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:47:14Z","timestamp":1773298034258,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bund gegen Alkohol und Drogen im Stra\u00dfenverkehr"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.011","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T23:30:26Z","timestamp":1487633426000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Effects of tetrahydrocannabinol on glucose uptake in the rat brain"],"prefix":"10.1016","volume":"117","author":[{"given":"I.","family":"Miederer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Uebbing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"R\u00f6hrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bausbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Krauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Weyer-Elberich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.011_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000068915","article-title":"The stimulatory effect of cannabinoids on calcium uptake is mediated by Gs GTP-binding proteins and cAMP formation","volume":"12","author":"Bash","year":"2003","journal-title":"Neuro-Signals"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB(1) receptors regulate neuronal energy metabolism","volume":"15","author":"Benard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0269881111408458","article-title":"The role of the endocannabinoid system in the neuroendocrine regulation of energy balance","volume":"26","author":"Bermudez-Silva","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.12.016","article-title":"Activation of cannabinoid CB1 receptors induces glucose intolerance in rats","volume":"531","author":"Bermudez-Siva","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bcp.2005.07.007","article-title":"CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin","volume":"70","author":"Bland","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/nbdi.1998.0229","article-title":"The functional neuroanatomy of brain cannabinoid receptors","volume":"5","author":"Breivogel","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib7","first-page":"1215","article-title":"Dissecting the cannabinergic control of behavior: the where matters. BioEssays : news and reviews in molecular","volume":"37","author":"Busquets-Garcia","year":"2015","journal-title":"Cell. Dev. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib8","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1210\/en.2012-1405","article-title":"Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice","volume":"153","author":"Cardinal","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/syn.20801","article-title":"Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210","volume":"64","author":"Dalton","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0001-4575(02)00153-7","article-title":"The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes","volume":"36","author":"Drummer","year":"2004","journal-title":"Accid. Analysis Prev."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0379-0738(03)00134-8","article-title":"The incidence of drugs in drivers killed in Australian road traffic crashes","volume":"134","author":"Drummer","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2015.06.028","article-title":"Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry. Journal of chromatography B","volume":"1001","author":"Eckart","year":"2015","journal-title":"Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/syn.10089","article-title":"Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat","volume":"45","author":"Freedland","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.molmet.2014.03.007","article-title":"Cannabinoid control of brain bioenergetics: exploring the subcellular localization of the CB1 receptor","volume":"3","author":"Hebert-Chatelain","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib15","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2017.02.011_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00406-007-1005-y","article-title":"Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?","volume":"258","author":"Hiemke","year":"2008","journal-title":"Eur. Archives Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib17","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib18","doi-asserted-by":"crossref","first-page":"ra23","DOI":"10.1126\/scisignal.2002519","article-title":"Cannabinoids induce pancreatic beta-cell death by directly inhibiting insulin receptor activation","volume":"5","author":"Kim","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature14260","article-title":"Hypothalamic POMC neurons promote cannabinoid-induced feeding","volume":"519","author":"Koch","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuropharm.2016.03.015","article-title":"Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease","volume":"110","author":"Kofalvi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(91)90281-T","article-title":"Delta 9-tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain","volume":"202","author":"Margulies","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metabolism Toxicol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00259-006-0121-7","article-title":"Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function","volume":"33","author":"Meyer","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainresbull.2011.11.011","article-title":"Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG","volume":"87","author":"Nguyen","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000542-198608000-00004","article-title":"Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat","volume":"65","author":"Ori","year":"1986","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib29","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410060502","article-title":"Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method","volume":"6","author":"Phelps","year":"1979","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainresbull.2016.05.009","article-title":"Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin","volume":"124","author":"Pinheiro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2003.10.008","article-title":"Dose related risk of motor vehicle crashes after cannabis use","volume":"73","author":"Ramaekers","year":"2004","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0269881108092393","article-title":"Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users","volume":"23","author":"Ramaekers","year":"2009","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2006.03.015","article-title":"Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment","volume":"85","author":"Ramaekers","year":"2006","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jat\/34.4.196","article-title":"Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop","volume":"34","author":"Rohrich","year":"2010","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jat\/34.3.155","article-title":"Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device","volume":"34","author":"Rohrich","year":"2010","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(02)00174-2","article-title":"The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells","volume":"101","author":"Rubovitch","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/clpt.2008.213","article-title":"Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9","volume":"85","author":"Sachse-Seeboth","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib39","series-title":"Methodenvalidierung im forensisch-toxikologischen Labor: Auswertung von Validierungsdaten nach den Richtlinien der GTFCh mit VALISTAT: Arvecon","author":"Schmitt","year":"2003"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(97)00422-X","article-title":"Biphasic effects of anandamide","volume":"59","author":"Sulcova","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib42","first-page":"1398","article-title":"Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. Journal of nuclear medicine : official publication","volume":"45","author":"Toyama","year":"2004","journal-title":"Soc. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.10.033","article-title":"A\u00a0single low dose of tetrahydrocannabinol induces long-term cognitive deficits","volume":"411","author":"Tselnicker","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neuropharm.2005.03.025","article-title":"Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol","volume":"49","author":"Verty","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib45","first-page":"879","article-title":"Adverse health effects of marijuana use","volume":"371","author":"Volkow","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0925-4927(91)90030-T","article-title":"Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose","volume":"40","author":"Volkow","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2017.02.011_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-001-0712-2","article-title":"A\u00a0femoral arteriovenous shunt facilitates arterial whole blood sampling in animals","volume":"29","author":"Weber","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuropharm.2017.02.011_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-002-1001-x","article-title":"Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat","volume":"161","author":"Whitlow","year":"2002","journal-title":"Psychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:49:34Z","timestamp":1758437374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":48,"alternative-id":["S0028390817300564"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727328371.793529072","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of tetrahydrocannabinol on glucose uptake in the rat brain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}